龍湖(00960.HK)回升6.5% 績後獲大行維持正面評級
去年少賺47%龍湖集團(00960.HK)績後獲里昂重申「買入」評級,目標價上調5.3%至12元,以反映公司利潤質量更高及組合更健康。野村績後維持龍湖「買入」評級,目標價降至17.1元。該股現報10.84元,回升6.5%,成交949萬股,涉資9,990萬元。
龍湖上周五中午公布,去年純利按年跌47%至128.5億元人民幣(下同),每股盈利2.07元,末期股息按年減少71%至0.23元,期內,總營收按年減約28%至1,807.37億元。此外,去年剔除公平值變動等影響後之股東應佔核心溢利113.5億元。截至去年底止,綜合借貸1,926.5億元,在手現金604.2億元,淨負債率55.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.